SYNBIOTIC

Investor Relation Portal

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Willkommen auf unserem

Investor Relation Portal

Wir vereinen Hanf & Cannabis Unternehmen unter einem Dach,
um Cannabinoide zugänglich zu machen.

ABOUT SYNBIOTIC

SYNBIOTIC SE is a leading European corporate group operating in the dynamic environment of the industrial hemp and cannabis market.

As a public listed company, SYNBIOTIC SE offers its investors the exceptional opportunity to fully capitalise on the potential of this rapidly growing market.

Our holding strategically invests in promising ventures within the industrial hemp, medical, and recreational cannabis sectors.

In doing so, we create profitable synergies across the entire value chain. Our expertise encompasses the entire process from cultivation and research to development, production, sales, and distribution of premium industrial hemp and cannabis products.

A special feature of SYNBIOTIC SE is the rigorous quality management throughout the entire production processes and supply chain, both fully covered by majority holdings. A unique selling point in the industry.

Due to our successful buy-and-build strategy, we continuously expand ourproduction and value chain, setting new standards in the industry.

SYNBIOTIC - Your Smartest Way to Invest in Cannabis.

more about synbiotic
+ 10
companies

joined our Platform

80+
WORKING TALENTS

to fulfill our Vision

Welcome to our
Investor Relations Portal

We unlock the power of cannabinoids to heal modern world diseases.

About the Stock

WKN:

A3E5A5

Ticker Symbol:

SBX

ISIN:

DE000A3E5A59

Shareholder Structure:

63 % Management & Founders

23 % other Institutionals

11 % Freefloat

Aktionärsstruktur:

Management & Founders ca. 71%

Institutional & Retail Shareholders ca. 29%

Stock Exchange:

Xetra, Düsseldorf, Tradegate, GETTEX

Total number of shares:

5.599.537

Share capital:

5.599.537,00

Downloads

Corporate Presentations​

Annual General Meetings

Annual General Meeting on August 05, 2021.

The Annual General Meeting of SynBiotic SE took place on Thursday, August 5, 2021, at 10:00 a.m. (CEST).

The Company's Annual General Meeting was held as a virtual general meeting without the physical presence of shareholders or their proxies (except for the Company's proxies).

Additional to Top 9:

There were no countermotions.

  • June 2024 | Annual financial statements 2023
  • August 2024 | Annual General Meeting 2024
  • September 2024 | Half-year financial statements 2024

Analysts

Recommendation

Target Price

Last Research

Analyst

44 EURO
BUY

Hauck & Aufhäuser

When time meets opportunity; initiate with a BUY

December 2022
August 2022
n/a
INITIATION

Edison Investment Research

SynBiotic appears cautiously valued

August 2023
15,20 Euro
BUY

Alster Research

Strong founder and owner network that has proven how to scale a platformcompany

August 2022
39,60 EURO
BUY

Baader Bank

Analysts

Recommendation

Target Price

Last Research

Analyst

October 2021
75 EURO
BUY

Hauck & Aufhäuser

When time meets opportunity; initiate with a BUY

July 2021
INITIATION

Edison Investment Research

SynBiotic appears cautiously valued

March 2022
47 Euro
BUY

Alster Research

Strong founder and owner network that has proven how to scale a platformcompany

December 2021
42,50 EURO
BUY

Baader Bank

Unsere Geschäftsbereiche

Industrial hemp

Our industrial hemp is used to manufacture sustainable products across various industries.

Medical cannabis

Medicinal cannabis used for therapeutic applications with patients.

Recreational cannabis

High-quality products for home cultivation. Up to 4,000 products in the range.